Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia
about
Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia
description
im Jahr 2016 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2016
@uk
name
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@en
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@nl
type
label
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@en
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@nl
prefLabel
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@en
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@nl
P2093
P2860
P921
P356
P1433
P1476
Jacalin-capped silver nanopart ...... human chronic myeloid leukemia
@en
P2093
Aravind Sivasubramanian
Khan Behlol Ayaz Ahmed
Kuntal Haldar
Mamilla R. Charan Raja
Megarajan Sengan
Narendran Rajendran
Sandeep Kumar Das
Santanu Kar Mahapatra
Shankar Subramaniam
Somenath Roy
P2860
P304
18980-18989
P356
10.1039/C5RA27952F
P577
2016-01-01T00:00:00Z